Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study by Bulgari, Viola et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.schres.2016.10.016
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Bulgari, V., Iozzino, L., Ferrari, C., Picchioni, M., Candini, V., De Francesco, A., ... de Girolamo, G. (2016).
Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study. Schizophrenia
Research. DOI: 10.1016/j.schres.2016.10.016
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
1 
 
Viola Bulgari1,2, Laura Iozzino3, Clarissa Ferrari4, Marco Picchioni5, Valentina 
Candini1,6, Alessandra De Francesco7, Paolo Maggi8, Beatrice Segalini9 and  
Giovanni de Girolamo1 on behalf of the VIORMED-1 Group* 
 
 
CLINICAL AND NEUROPSYCHOLOGICAL FEATURES OF VIOLENCE IN 
SCHIZOPHRENIA: A PROSPECTIVE COHORT STUDY  
 
 
 
1 Psychiatric Epidemiology and Evaluation Unit, Saint John of God Clinical Research 
Center, Brescia, Italy 
2 PhD School in Psychology, Catholic University of the Sacred Heart, Milan, Italy 
3Department of Neurosciences, Biomedicine and Movement Sciences, University of 
Verona, Italy 
4 Service of Statistics, Saint John of God Clinical Research Center, Brescia, Italy 
5Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, 
Psychology and Neuroscience, King’s College of London, UK 
6 Department of Psychology, University of Padua, Italy  
7Rehabilitation Hospital Beata Vergine della Consolata, Turin, Italy 
8Sacro Cuore di Gesù Center, Milan, Italy  
9Villa Sant’Ambrogio Hospital, Milan, Italy 
 
Corresponding Author:  
Dr. Viola Bulgari 
Saint John of God Clinical Research Center 
Via Pilastroni 4, 25125 Brescia (Italy) 
Phone number: 0039 030 3501742 
Fax number: 0039 030 3533513 
Email address: vbulgari@fatebenefratelli.eu 
2 
 
*The VIORMED-1 Group includes: Suor Andreose, M.D., Pasquale Basso, M.D., Rossella 
Beneduce, M.D., Pietro Bertolotti, M.D., Maria Elena Boero, M.D., Marina Bonelli, M.D., 
Fanny Bongiorno, M.D., Vanda Braida, M.D., Riccardo Bussi, M.D.,  Elisa Castagno, M.D., 
Giuseppe Cristiano, M.D., Fabio Dominicis, M.D., Loredana Ghersi, M.D., Gian Marco 
Giobbio, M. D., Stefania Greppo, M.D., Alessandro Jaretti Sodano, M.D., Massimo 
Leporatti, M.D., Eleonora LoPresti, M.D., Fausto Panigada, M.D., Livia Pasquadibisceglie, 
M.D., Danilo Rigamonti, M.D., Luciana Rillosi, M.D., Giuseppe Rossi, M.D. 
3 
 
ABSTRACT  
The increased risk of violence in schizophrenia has been linked to several 
environmental, clinical and neuropsychological factors, including executive dysfunction. 
However, data about the nature of these effects are mixed and controversial. The main aim 
of this study was to investigate the relationship between clinical and neuropsychological 
factors with violence risk in patients with schizophrenia, taking into account current 
psychopathology and lifetime alcohol use. We compared a sample of patients living in 
Residential Facilities (RFs) with schizophrenia and a past history of interpersonal violence 
(vSZ, N=50) to patients with schizophrenia matched on age, gender and alcohol 
abuse/dependence but with no violence history (nvSZ, N=37). We then established the 
association between the clinical and neuropsychological factors that predicted violence 
over a 1 year follow-up period. The results revealed that vSZ patients living in RFs were 
characterized by greater compulsory hospital admissions, higher anger and less negative 
symptoms as compared to nvSZ patients. vSZ patients performed better on executive and 
motor tasks than nvSZ; however, these differences appeared to be explained by the lower 
negative psychotic symptom in the vSZ group. Both groups were involved in episodes of 
violence during the follow-up period; among the two, the vSZ patients were more likely to 
be violent. Negative symptoms predicted less verbal aggression at 1 year follow-up. 
Overall, these findings support a key role of negative rather than positive symptoms in 
driving violence risk among SZ patients living in RFs, in a manner that negative 
symptoms are linked to a lower risk of violence. 
 
Key words: Cognition, Violence, Schizophrenia, Residential Facilities 
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1. INTRODUCTION  
People with schizophrenia are more likely to be violent than people with other 
mental disorders or the general population (Walsh et al., 2002). The relationship between 
schizophrenia and violence is complex because of the interplay between many factors, 
such as having a past history of violence ( Iozzino et al., 2015), age and gender (Swanson et 
al., 1990; Dack et al., 2013), current psychotic symptoms and childhood conduct problems 
(Hodgins, 2008), alcohol and substance misuse (Bowers et al., 2009). 
From a neuropsychological perspective, deficits in executive functioning may be 
key components in the pathway that increases the propensity to violence in some patients 
with schizophrenia. This is consistent with evidence that abnormalities in fronto-temporal 
circuitry are implicated in aggressive behavior among such patients (Weiss, 2012). 
Executive functions embrace higher order cognitive functions mainly sustained by 
prefrontal cortex, including mental flexibility, response inhibition, problem solving, self-
monitoring and the ability to use feedback to modulate behavior (Lezak, 1995; Miyake et 
al., 2000). They may be modulated by dynamic factors, as psychotic symptoms (Bora et al., 
2009), mood (Volkow, 2009) and alcohol/substance use (Harvey, 2011; Donoghue and 
Doody, 2012). 
Data exploring the link between executive deficits and risk of violence in 
schizophrenia are inconsistent (Weiss et al., 2012; Witt et al., 2013). Current 
psychopathology, social reasoning and functioning have also been reported to be linked to 
violence (Serper et al., 2008; O’Reilly et al., 2015), though a recent meta-analysis found that 
only global cognitive impairment and lack of insight predicted violence in schizophrenia 
(Reinharth et al., 2014). 
Methodological challenges may help explain some of these inconsistencies, 
including small sample sizes, diagnostic heterogeneity, different clinical settings (i.e., 
community outpatient services, acute inpatient units and specialized forensic units), lack 
of standardization in the quantification of violence (Harris et al., 2013) and a failure to 
assess dynamic factors (Rueve and Welton, 2008; Dack et al., 2013). 
The main aim of this study was to establish whether cognitive deficits are linked to 
the propensity to violence in patients with schizophrenia living in Residential Facilities 
(RFs). We examined the demographic and clinical characteristics of patients with 
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schizophrenia and a history of violence (vSZ) compared to those with no history of 
violence (nvSZ) (aim i). We compared these two groups on cognitive performances, taking 
into account potential confounding factors such as psychopathology and lifetime use of 
alcohol (aim ii). We then measured further acts of violence over 1 year (aim iii) and 
prospectively tested the roles of clinical and cognitive features in predicting the violence 
risk (aim iv).  
We hypothesized that vSZ patients would exhibit higher anger scores and lifetime 
problematic alcohol use than nvSZ (i), and that vSZ patients would demonstrate impaired 
executive performances compared to nvSZ at baseline (ii). We also hypothesized that vSZ 
patients would be involved in higher rates of violence than nvSZ over the 1 year period 
(iii) and that current psychopathology and executive performance would predict that 
violence risk (iv). 
 
2. MATERIAL AND METHODS 
2.1 Study design and participants 
This study was part of the VIOlence Risk and MEntal Disorders’ (‘VIORMED’) 
project (de Girolamo et al., 2016). Patients were recruited from medium-long term RFs in 4 
centers of the Saint John of God Order in Italy between May and September 2013. All RFs 
were non-hospital facilities which care for long-term psychiatric patients. In Italy in 2000 
there were 1,370 RFs with 17,138 beds; most of them had 24-hour staffing with 1.42 
patients per full-time worker and 12.5 beds per RF on average (de Girolamo, et al., 2002).  
Fifty patients with schizophrenia and a past history of violence (vSZ) and 37 
patients with schizophrenia without a violence history (nvSZ) were recruited, matched on 
age, gender and lifetime alcohol abuse/dependence as secondary diagnoses. We focused 
on alcohol because it was the most commonly abused drug in our sample; indeed all 
patients with lifetime abuse of other substances also abused of alcohol. Six eligible 
participants refused to participate. 
All subjects had a primary diagnosis of a DSM-IV schizophrenia spectrum disorder 
(APA, 1994) as ascertained with the SCID-I (First et al., 2002), were aged between 18-65 
years, lived in a RF at recruitment and were Italian fluent. Exclusion criteria were a 
diagnosis of mental retardation, dementia, organic brain disorder, or cancer. The study 
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was approved by the Ethical Committee (EC) of the Saint John of God Clinical Research 
Center in Brescia (Italy) as coordinating site, and by ECs of the other centers. All patients 
gave their written informed consent before entering the study. 
2.2 Definition of “history of violence” 
We defined “history of violence” as a categorical variable if the patient had 
committed an act of severe interpersonal violence in the last 10 years, as reported in the 
clinical records. Only “violent acts committed against others which caused (or might have 
caused) physical harm to the victim” were considered. If a patient committed several 
violent acts within this time frame, we included the act that had the most severe physical 
consequences for the victim. 
2.3 Socio-demographic and clinical factors 
Socio-demographic and clinical information were collected through a specific form 
at study entry; this tool also included an assessment of the past history of violence, such as 
age, mental state and type of violence, based on patients’ clinical records and interviews. 
Lifetime substance abuse was assessed using SCID-I. Current psychopathology was also 
evaluated using the Brief Psychiatric Rating Scale (BPRS) (Ventura et al., 1993) to yield 
total, positive and negative psychotic symptom scores (Ungvari et al., 2008). Psychosocial 
functioning was measured with Personal and Social Performance Scale (PSP) (Morosini et 
al., 2000) and patients’ self-awareness about their disorder using the Insight Scale (IS) 
(Markovà et al., 2003). 
Lifetime aggressive behaviour was assessed through the Brown–Goodwin Lifetime 
History of Aggression (BGHA) (Brown et al., 1979). Impulsivity and anger were evaluated 
by the Barratt Impulsiveness Scale-11 (BIS-11) (Fossati et al., 2001) and the State-Trait 
Anger Inventory-2 (STAXI-2) (Cumunian, 2004). 
2.4 Neuropsychological assessment  
All patients underwent a neuropsychological assessment over a maximum of two 
sessions of about 45 minutes at study entry. All tests were administered and scored 
according to standard procedures. 
The Brief Assessment of Cognition in Schizophrenia (BACS) (Anselmetti et al., 2008) 
was used to assess cognition broadly. The BACS evaluates verbal memory, working 
memory, motor speed, verbal fluency, attention and speed of information processing, and 
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planning. The cognitive foci were working memory (Digit Sequencing Task), motor speed 
(Token Motor Task), speed of information processing and attention (Symbol Coding Test). 
The Wisconsin Card Sorting Test (WCST) (Laiacona et al., 2000) was used to test 
executive functioning. WCST performance was indexed using the total score, the number 
of perseverations and not perseverative errors as index of mental flexibility and inhibition. 
The Iowa Gambling Test (IGT) requires inhibitory control and learning from 
external feedbacks. We employed an experimental computerized IGT task based on the 
original version (Bechara et al., 1994). The task involved four visually similar decks of 
cards, which can either provide high rewards and losses (disadvantageous decks: A and B) 
or small rewards and losses (advantageous decks: C and D). The aim is to maximize the 
starting budget of $ 2,000. The subject is allowed to pick from any of the decks for a total of 
100 cards, one at a time. After turning a card, the subject is informed of their gain or loss. 
Performance was evaluated in final total budget and net score. The net score was 
calculated as [(C+D) – (A+B)], where positive net score reflects advantageous performance 
and negative net score reflects disadvantageous performance.  
2.5 Monitoring violence during the 1 year follow-up 
Patients’ behavior was reviewed twice a month by medical staff blind to the 
baseline evaluations. The Modified Overt Aggression Scale (MOAS) (Margari et al., 2005) 
was used to rate the most severe violent behavior exhibited in the previous two weeks 
across four domains of violence: verbal, physical, against property and self-aggression. 
Thus, each patient had a total of 24 MOAS evaluations. For patients discharged from the 
RF, the new treating psychiatrist (at the Department of Mental Health, DMH, or in another 
RF) was contacted to complete the MOAS. Weighted scoring of the MOAS was used 
throughout (Kay et al, 1988). 
To select violent acts of at least low-moderate severity, those patients who had a 
total MOAS score ≥3 were categorized as ‘new violent’ and included in the analyses of 
predictors. 
2.6 Follow-up at 1 year 
At the end of the monitoring, patients were reassessed using BPRS, FPS, STAXI-2 
and BIS-11.  
2.7 Statistical analysis 
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Socio-demographic and clinical characteristics were compared between the two 
groups (vSZ vs nvSZ) using the appropriate statistics according to the nature of the data (t-
test with Cohen’s d and its 95% confidence interval for continuous variables, and Chi-
square with Odds Ratios (OR), and its 95% confidence interval for categorical variables). 
Adjusted scores were considered for neuropsychological measures based on their Italian 
validation. Group differences of cognitive variables were assessed with and without 
adjustments for BPRS Negative Score and lifetime problematic use of alcohol as covariates, 
with ANOVA and ANCOVA models respectively. Coefficient of determination R2 and the 
partial eta square effect size were computed in order to describe the ratio of variance 
explained in the dependent variable by a predictor while controlling for other predictors.  
Given the non-Gaussian (skewed and zero-inflated) distribution of the MOAS score, 
generalised linear models with tweedie distribution and log-link function were adopted 
for analysing the predictors of violent behaviour. Total MOAS score (and MOAS 
subscales) was used as dependent variable; continuous and categorical measures as 
independent variables. 
All tests were two-tailed, with statistical significant set at p= 0.05. All data were 
analysed using the SPSS Statistics for Windows, Version 21.0. 
 
3. RESULTS 
3.1 Socio-demographic and clinical factors 
The groups did not differ on any socio-demographic variables at baseline (Table 1). 
The vSZ group had higher BGHA scores (t=2.4, p=0.019, d=0.5 [0.1, 0.9]) and were more 
often admitted compulsorily over their lifetime (t=5.0, p<0.001, d=1.2 [0.7, 1.6]) than the 
nvSZ group. The groups did not differ on rates of lifetime problematic alcohol use (X2=2.1, 
p=0.147, OR=0.5 [-0.2, 1.3]). 
Even if it did not reach statistical significance, the vSZ group had lower total BPRS 
and higher PSP scores than the nvSZ group at study entry. The vSZ groups were rated 
significantly lower on the BPRS Negative Scale (t=-3, p=0.004, d=-0.6 [-1.1, -0.2], but higher 
for STAXI-2 RT/R (t=2.0, p=0.049, d= 0.4 [0, 0.8]) and STAXI-2 ER/Out indices (t=3.3, p= 
0.002, d= 0.7 [0.2, 1.1]), which respectively refer to the tendency of experiencing anger 
during frustrating situations, and of exhibiting anger toward others or objects. 
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TABLE 1 
3.2 Assessment of violence history 
The majority of vSZ patients were already known to a DMH at the time of their 
violent act (N=36, 72%). Forty-four individuals committed some forms of severe assaults, 
that ranged from striking someone to attempted murder and murder. One committed 
stalking. The most violent acts occurred in the context either of impulse dysregulation 
(N=34, 68%) or in a delusional state (N=36, 72%). Rates of alcohol or drug intoxication 
were relatively uncommon at the time of the assaults (N=14, 28%). 
3.3 Neuropsychological assessment 
Even under the cut-off (Table 2), the vSZ group outperformed the nvSZ group on 
several BACS and WCST measures. vSZ subjects had significantly higher BACS motor 
speed score (F=7.60, p=0.007, η2=0.1), lower WCST Global Score (F=5.39, p=0.023, η2=0.1) 
and Perseverations (F=5.24, p=0.025, η2=0.1) compared to the nvSZ group. On the IGT, vSZ 
patients performed less well than controls, though the differences were not significant. 
Since the vSZ and nvSZ groups differed significantly on negative psychotic 
symptoms and previous work suggested associations between psychotic psychopathology 
and alcohol abuse on cognition, we decided to enter the BPRS Negative Score and a 
lifetime problematic use of alcohol into the ANCOVA model. When those covariates were 
entered, BACS motor speed, WCST Global Scores and Perseverations no longer differed 
significantly between groups ( F=2.34, p=0.130, η2=0.03; F=2.45, p= 0.122, η2=0.03, and 
F=2.56, p=0.114, η2=0.03, respectively). Only the BPRS Negative score had a significant 
effect on BACS Token Motor Task, WCST Global Score and Perseverations. 
TABLE 2 
3.4 Violence during the 1 year follow-up 
The vSZ patients (N=50) yielded significantly higher scores in the total and verbal 
MOAS mean scores compared to nvSZ patients (N=37). In details, for total score vSZ had a 
mean of 6.9 (Standard Error=1.4) vs nvSZ with a mean of 2.4 (SE=1.2) (t=2.4, p=0.018); for 
verbal aggression score: vSZ mean=3.3 (SE=0.8) vs nvSZ mean=0.9 (SE=0.3) (t=2.8, 
p=0.006). vSZ patients also obtained higher scores at aggression against property score 
(vSZ mean=1.1, SE=0.3 vs nvSZ mean=0.8, SE=0.5; t=0.4, p=0.680), self-aggression score 
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(vSZ mean=0.06, SE=0.06 vs nvSZ mean=0) and physical aggression score (vSZ mean=2.4, 
SE=0.8 vs nvSZ mean=0.6, SE=0.5; t=1.9, p=0.062). 
As we screened for the total MOAS score ≥3, twenty-eight individuals (32%) were 
classified as ‘new violent’ patients. Twenty-two (44%) belonged to the vSZ group and 6 
(16%) to the nvSZ group, showing a significant association between having a history of 
violence and new episodes of violence (X2=7.5, p=0.006). They committed a total of 48 new 
episodes of violence, including 25 episodes of verbal aggression, 11 acts of property 
violence, 10 acts of interpersonal violence and 2 of self-aggression. The MOAS mean scores 
(of each subscale) of the ‘new violent’ patients are shown in Figure 1.  
Figure 1 
3.5 Prediction of aggression during 1 year follow-up  
Generalized linear models were used to predict violence propensity indexed on the 
MOAS over 1-year follow-up period (Table 3). Twenty-eight patients classified as “new 
violent” were included in this analysis. Variables that were significant in the previous 
analyses, baseline BPRS Negative symptom score, BGHA, STAXI-2_RT_R, STAXI-
2_ER_out, WCST Perseveration, BACS Token Task and history of violence, were included 
as independent variables. Only the BPRS Negative symptom score significantly predicted 
MOAS verbal aggression in an inverse manner (β=-0.55, p<0.001), meaning that higher 
levels of negative symptoms were associated with a lower risk of verbal aggression. The 
association between BPRS Negative Score and MOAS verbal aggression remained 
significant (β=-0.11, p=0.008) after adjusting for the history of violence (vSZ vs nvSZ). 
TABLE 3 
 
4. DISCUSSION 
This is one of the first studies that aimed to prospectively identify the clinical and 
neuropsychological features of violent behavior among patients with schizophrenia living 
in RFs.  
The majority of vSZ patients were followed-up by DMHs at the time of their violent 
act. This may demonstrate the difficulty to make accurate risk predictions to prevent 
violence. vSZ patients were more likely to have been admitted involuntarily in the past 
and showed higher BGHA scores.  
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As in Candini et al. (2015), the violent group had lower levels of negative symptoms 
and better global functioning compared to controls. Negative symptoms have also been 
shown to characterize schizophrenia patients at a lower risk of violence in the community 
(Swanson et al., 2006). 
Although there were no group differences in impulsivity on the BIS-11, results from 
STAXI-2 revealed that vSZ patients were more likely to experience and exhibit anger than 
controls. Indeed, violence is the external expression of anger (Spielberger and Sydeman, 
1994) and may play a crucial role in linking psychotic symptoms with violence (Coid et al., 
2013; Ullrich et al., 2014). 
Contrary to our hypothesis, vSZ patients outperformed controls on executive tasks 
in a manner that has been found in the past (Lapierre et al., 1995; Rasmussen et al., 1995). 
Further, we found that this was primarily linked to lower levels of negative symptoms 
(i.e., blunted affect, withdrawal, disorientation) in the vSZ group, through an inverse 
correlation between cognitive performances and the severity of negative psychotic 
symptoms. 
Twenty-eight (32%) patients were violent during the 1 year follow-up period. 
Despite the heterogeneity of violence types, this result is broadly in line with the small 
number of studies which reported violence rates that ranged between 11 and 50% in 
psychiatric residential settings (Flannery et al., 2000a; 2000b).  
It is interesting to note that while 44% of those who have a past history of violence 
continued to act violently in the RFs, the majority (56%) were not. These findings could be 
linked to the relatively high levels of clinical stability that the patients achieved in these 
RFs, linked to high compliance with both medical and psychosocial interventions (de 
Girolamo et al., 2005). 
4.1 Strengths  
This study is one of the first to prospectively investigate the association between 
clinical, neuropsychological factors and violence risk in a relatively large sample of 
patients with schizophrenia. We focused on schizophrenia spectrum disorders as these 
represent the most frequent diagnostic group in these RFs.  
Further, it employed a comprehensive multidimensional assessment strategy and a 
standardized instrument to quantify violence over the follow-up period. 
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The results may help define the clinical profile of patients with schizophrenia who 
pose the greatest risk of violence, and provide insights to inform future research as well as 
violence prevention and treatment. 
4.2 Limitations 
As we considered long-term patients with schizophrenia in RFs, our results are not 
generalizable to other diagnostic groups or patients living in the community. Similarly, we 
were unable to assess the effect of medication on violence and cognition.  
We did not include IQ measures; however, a clinical diagnosis of mental retardation 
was an exclusion criterion. We only included a problematic use of alcohol, as it was the 
substance abused by all the patients.  
Violence history was dichotomized in vSZ and nvSZ groups. It was assessed from 
medical charts, as this was the source of information available for all patients living in RFs.  
 
5. CONCLUSIONS 
While there is an association between schizophrenia and violence risk, the 
assessment of that risk remains a difficult area of investigation, which can delay patients 
discharge to more independent community settings. In our study, only a minority of 
patients were violent during the 1 year follow-up. A history of past violence, greater 
compulsory admissions, higher anger, lower psychotic negative symptoms and better 
executive functioning distinguished vSZ from nvSZ patients. However, only negative 
symptoms were linked to cognition and predicted violence at 1 year. More research is 
needed to improve our understanding of the relationship between violence, cognition and 
schizophrenia in residential and other settings. 
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Figure legend 
 
Figure 1. ‘New violent patients’ (N=28): mean MOAS scores with 
standard errors bars across 24 evaluations (1 year follow-up).  
 
 
Table legend  
    
Table 1. Socio-demographic and clinical characteristics, self-reported 
impulsivity and aggression. 
 
Table 2. Neuropsychological scores differences between groups with 
and without adjustment for BPRS Negative Score and lifetime 
problematic use of alcohol as covariates. 
 
Table 3. Predictors of violence during 1 year follow-up (total MOAS 
score ≥3). 
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Table 1. Socio-demographic and clinical characteristics, self-reported impulsivity and 
aggression. 
 
 vSZ (n=50) 
N (%)                   Mean (SD) 
nvSZ (n=37) 
N (%)                     Mean (SD) 
Statistical Test,  
p-value 
Effect size 
[95% CI] 
Gender male 46 (92%)  32 (86.5%)  X2=0.7, p=0.486 OR=1.8 
[-0.4, 7.2] 
Age (years)  46.7  (10.0)  49.2 (9.9) t=-1.2, p=0.244 d=-0.3 
[-0.7, 0.2] 
Education        
Primary school 42 (84%)  32 (86.5%)  X2=0.1, p=0.748 OR=0.8 
Professional and high school 8 (16.0%)  5 (13.5%)   [-0.2, 2.7] 
Occupation 
Unemployed  
Employed  
 
42 (85.7%) 
7 (14.3%) 
  
36 (97.3%) 
1 (2.7%) 
  
X2=3.4, p=0.130 
 
 
OR=0.2 
[-0.02, 1.4] 
Age at the first contact 
with the DMH (years)  
  27.4  (9.4)  24.2 (6.8) t=1.6, p=0.105 d=0.4 
[-0.1, 0.8] 
Mean duration of the 
schizophrenia disorder 
(years) 
 34.2 (30.4)  30.5 (19.0) t=0.7, p=0.492 d=0.1 
[-0.3, 0.57] 
Length of stay in the last 
Residential Facility (years) 
 3.4 (4.2)  3.0 (3.5) t=0.4, p=0.669 d=0.1 
[-0.3, 0.5] 
Lifetime number of 
compulsory admissions  
 1.9 (1.0)  0.8 (0.8) t=5.0, p<0.001 d=1.2 
[0.7, 1.6] 
Lifetime problematic use 
of alcohol 
18 (36.0%)  8 (21.6%)  X2=2.1, p=0.147 OR=0.5 
[-0.2, 1.3] 
First generation 
antipsychotics  
32 (65.3%)  18 (54.5%)  X2=1.0, p=0.327 OR=0.6 
[-0.3, 1.6] 
Second generation 
antipsychotics  
41 (83.7%)  26 (78.8%)  X2=0.3, p=0.575 OR=0.7 
[-0.2, 2.2] 
BPRS Total Score   58.5 (25.0)  63.2 (19.5) t=-1.0, p=0.336 d=-0.2 
[-0.6, 0.2] 
BPRS Positive Score   14.0 (7.1)  13.7 (4.8) t= 0.1, p=0.911 d=0.1 
[-0.4, 0.5] 
BPRS Negative Score   8.9 (4.3)  11.9 (5.2) t=-3.0, p=0.004 d=-0.6 
[-1.1, -0.2] 
IS  11.7 (6.7)  13.5 (6.6) t=1.267, p=0.209 d=-0.3 
[-0.7, 0.2] 
PSP   38.6 (16.1)  37.2 (15.8) t=0.4, p=0.688 d=0.1 
[-0.3, 0.5] 
BGHA   38.9 (12.5)  32.6 (11.0) t=2.4,  p=0.019 d=0.5 
[0.1, 0.9] 
BIS-11   64.9 (12.2)  67.6 (13.8) t=-0.95, p=0.345 d=-0.2 
[-0.6, 0.2] 
STAXI-2 _RT_R  7.2 (3.2)  6.1 (1.9) t=2.0, p=0.049 d=0.4 
[0, 0.8] 
STAXI-2 _ER_out  15.5 (6.4)  11.9 (3.4) t=3.3, p=0.002 d=0.7 
[0.2, 1.1] 
V: violent; Nv: not violent; SZ: schizophrenia; DMH: Department of Mental Health; BPRS: Brief 
Psychiatric Rating Scale; IS: Insight Scale; PSP: Personal and Social Performance Scale; BGHA: 
Brown–Goodwin Lifetime History of Aggression; BIS-11: Barratt Impulsiveness Scale-11; STAXI-2: 
State-Trait Anger Inventory-2. Mean (SD) for continuous variables and frequency and percentage 
for categorical variables are reported. Bold data indicate tests in which vSZ and nvSZ patients 
showed significant different scores. OR: odds ratio; d: Cohens’d, CI: Confidence Interval 95%. 
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Table 2. Neuropsychological scores differences between groups with and without adjustment for BPRS Negative Score and 
lifetime problematic use of alcohol as covariates. 
 
 
V: violent, Nv: not violent, SZ: schizophrenia; BACS: Brief Assessment of Cognition in Schizophrenia; WCST: Wisconsin Card Sorting Test; IGT: 
Iowa Gambling Task; na: not applicable. Raw scores are indicated (mean and standard deviation between blankets). Cut-off scores according to 
Italian normative data are reported. Bold data indicate test in which significant group differences were found. 
Fa F statistic of ANOVA model with no covariates. 
Fb F statistic of ANCOVA models with BPRS Negative Score and lifetime problematic use of alcohol as covariates. 
R2a coefficient of determination of ANOVA model with no covariates. 
R2b coefficient of determination of ANCOVA model with BPRS Negative Score and lifetime problematic use of alcohol as covariates. 
η2a eta-squared of ANOVA model with no covariates. 
η2b eta-squared of ANCOVA model with BPRS Negative Score and lifetime problematic use of alcohol as covariates. 
# BPRS Negative Score significantly affects the outcomes 
Outcomes vSZ (n=50) 
Mean  (SD) 
nvSZ (n=37) 
Mean  (SD) 
Cut-
off 
Fa  R2a Partial 
η2a 
p-value Fb  R2b Partial 
η2b 
p-value 
BACS List Learning  35.1  (11.9) 30.5 (13.2) >33.01 2.68 0.03 0.03 0.105 0.21 0.2 0.1 0.651 
BACS Digit Sequencing 
Task 
 14.5 (5.9) 14.1 (6.1) >14.93 0.08 0.0 0.0 0.78 0.75 0.1 0.01 0.39 
BACS Token Motor Task 48.0 (19.4) 35.7 (19.9) >68.77 7.60 0.1 0.1 0.007 2.34 0.3 0.03 0.130# 
BACS Verbal Fluency 32.2 (13.0) 28.7 (14.9) >31.68 1.24 0.01 0.01 0.268 0.14 0.3 0.0 0.708 
BACS Symbol Coding 18.0 (12.0) 14.6 (10.8) >40.49 1.68 0.02 0.02 0.198 0.01 0.2 0.0 0.945 
BACS Tower of London 10.8 (7.9) 9.5 (7.4) >12.37 0.51 0.0 0.0 0.478 0.31 0.2 0.0 0.578 
WCST Global score 71.4 (36.9) 90.6 (31.7) <90.6 5.39 0.1 0.1 0.023 2.45  0.1 0.03 0.122# 
WCST Perseveration 30.9 (20.4) 46.5 (37.3) <42.7 5.24 0.1 0.1 0.025 2.56 0.1 0.03 0.114# 
WCST Errors 34.7 (29.4) 44.4 (33.0) <30.0 1.75 0.02 0.02 0.190 0.21 0.1 0.0 0.651 
IGT Final Budget 1,595.19 
(1,272.94) 
1,895.6 (914.1) na 1.35 0.02 0.02 0.248 0.31 0.1 0.0 0.581 
IGT Net score -4.4 (46.9) 7.2 (34.3) na 1.47 0.02 0.02 0.230 0.20 0.1 0.0 0.653 
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Table 3. Predictors of violence during 1 year follow-up (total MOAS score ≥3). 
 
Predictors MOAS total 
score 
 
Β (p-value) 
MOAS-
Verbal 
aggression 
 
Β (p-value) 
MOAS-
Aggression 
against property 
 
Β (p-value) 
 
MOAS- Physical 
aggression 
 
Β (p-value) 
BPRS Negative Score -0.70 (0.061) -0.55 (<0.001) -1.12 (0.197) 0.09 (0.836) 
BGHA 0.09 (0.499) -0.004 (0.758) -0.03 (0.294) 0.02 (0.262) 
STAXI2 _RT_R 0.38 (0.558) 0.52 (0.195) -0.05 (0.724) 0.01 (0.924) 
STAXI2 _ER_out -0.10 (0.713) -0.10 (0.713) -0.01 (0.781) -0.01 (0.908) 
BACS Token task -0.06 (0.556) 0.09 (0.146) -0.01 (0.608) -0.02 (0.332) 
WCST Perseveration 0.11 (0.424) 0.01 (0.929) 0.02 (0.365) 0.01 (0.688) 
History of violence (yes vs no) 0.08 (0.793) 0.42 (0.269) -0.82 (0.261) 0.31 (0.731) 
 
V: violent, Nv: not violent, SZ: schizophrenia; MOAS: Modified Overt Aggression Scale; BPRS: Brief Psychiatric Rating Scale; BGHA: Brown–
Goodwin Lifetime History of Aggression; STAXI-2: State-Trait Anger Inventory-2; BACS: Brief Assessment of Cognition in Schizophrenia; WCST: 
Wisconsin Card Sorting Test. Bold data indicate a significant association. Note: Among patients with total MOAS ≥3, the MOAS “Self-aggression” 
subscale was constantly equal to zero; thus, it was not evaluated here. 
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Figure 1. ‘New violent patients’ (N=28): mean MOAS scores with standard errors bars across 24 evaluations (1 year follow-up). 
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Details of data presented in Fig. 1. Scatterplots of individual mean MOAS total scores and individual mean MOAS 
subscale scores. 
 
